Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Interest & Investment Income (2016 - 2025)

CorMedix (CRMD) has disclosed Interest & Investment Income for 13 consecutive years, with $889981.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 74.3% to $889981.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, up 49.13% year-over-year, with the annual reading at $3.8 million for FY2025, 49.13% up from the prior year.
  • Interest & Investment Income hit $889981.0 in Q4 2025 for CorMedix, down from $1.6 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.6 million in Q3 2025 to a low of $3022.0 in Q3 2021.
  • Historically, Interest & Investment Income has averaged $448801.4 across 5 years, with a median of $510593.0 in 2024.
  • Biggest five-year swings in Interest & Investment Income: plummeted 94.23% in 2021 and later surged 4102.08% in 2022.
  • Year by year, Interest & Investment Income stood at $4367.0 in 2021, then soared by 4102.08% to $183505.0 in 2022, then skyrocketed by 317.01% to $765241.0 in 2023, then plummeted by 33.28% to $510593.0 in 2024, then soared by 74.3% to $889981.0 in 2025.
  • Business Quant data shows Interest & Investment Income for CRMD at $889981.0 in Q4 2025, $1.6 million in Q3 2025, and $828949.0 in Q2 2025.